Suppr超能文献

婴儿肌纤维瘤病:小肿块引发大问题。

Infantile myofibromatosis: Small bumps pose big problems.

作者信息

Lee Hillary C, Amin Amee A, Chikwava Kudakwashe R, Smith Valeria R, Fernandes Caraciolo J

机构信息

Section of Neonatal-Perinatal Medicine, Department of Pediatrics, Baylor College of Medicine/Texas Children's Hospital, Houston, TX, USA.

Department of Pathology and Immunology, Baylor College of Medicine/Texas Children's Hospital, Houston, TX, USA.

出版信息

J Neonatal Perinatal Med. 2025 Mar;18(2):179-183. doi: 10.1177/19345798251318587. Epub 2025 Feb 5.

Abstract

BackgroundInfantile myofibromatosis (IM) is a disorder characterized by proliferation of benign myofibroblastic tumors that typically manifest as solitary or multiple nodules in the skin, muscle, bone, subcutaneous tissues, and visceral organs and can pose significant morbidity and mortality risks, particularly in cases involving visceral organs or causing functional impairment. These soft tissue lesions are the most prevalent benign fibrous tumors that present before age two and can undergo spontaneous regression or are amenable to surgical resection.CaseA preterm, male infant was born via Caesarean section to a mother with a trichorionic, triamniotic pregnancy following preterm labor. Within the first week of life, several well-circumscribed, smooth, non-tender, and soft nodules with some mobility were noticed along the border of the ribs, across the trunk, back, and lower extremities. Ultrasound imaging confirmed well-circumscribed hypoechoic, intramuscular nodules, and biopsy evaluation showed atypical spindle cell proliferation. The biopsied lesion was -mutated on molecular genetic studies, confirming a diagnosis of myofibromatosis. The infant developed mixed lytic and sclerotic deformities of a variety of bones, necessitating treatment given disease progression.ConclusionSuccessful clinical management with low-dose metronomic chemotherapy (methotrexate and vinblastine) is possible and can treat extensive disease, as seen in our patient.

摘要

背景

婴儿肌纤维瘤病(IM)是一种以良性肌成纤维细胞肿瘤增殖为特征的疾病,通常表现为皮肤、肌肉、骨骼、皮下组织和内脏器官中的单个或多个结节,可能带来显著的发病和死亡风险,特别是在内脏器官受累或导致功能障碍的情况下。这些软组织病变是两岁前最常见的良性纤维性肿瘤,可自发消退或适合手术切除。

病例

一名早产男婴通过剖宫产出生,其母亲为三绒毛膜、三羊膜妊娠,此前发生早产。在出生后的第一周内,沿肋骨边缘、躯干、背部和下肢发现了几个边界清晰、光滑、无压痛且质地柔软、有一定活动度的结节。超声成像证实为边界清晰的低回声肌内结节,活检评估显示非典型梭形细胞增殖。分子遗传学研究显示活检病变存在突变,确诊为肌纤维瘤病。婴儿出现了多种骨骼的混合性溶骨性和硬化性畸形,鉴于疾病进展需要进行治疗。

结论

如我们的患者所示,采用低剂量节拍化疗(甲氨蝶呤和长春碱)进行成功的临床管理是可行的,并且可以治疗广泛性疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f4e5/12231786/64dd18be8679/10.1177_19345798251318587-fig1.jpg

相似文献

1
Infantile myofibromatosis: Small bumps pose big problems.
J Neonatal Perinatal Med. 2025 Mar;18(2):179-183. doi: 10.1177/19345798251318587. Epub 2025 Feb 5.
2
The Black Book of Psychotropic Dosing and Monitoring.
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
4
Multicentric infantile myofibromatosis with extensive visceral involvement in a newborn: case report.
Ital J Pediatr. 2025 Jul 8;51(1):215. doi: 10.1186/s13052-025-02055-y.
5
Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.
Cochrane Database Syst Rev. 2019 Nov 20;2019(11):CD012024. doi: 10.1002/14651858.CD012024.pub3.
7
Prenatal administration of progestogens for preventing spontaneous preterm birth in women with a multiple pregnancy.
Cochrane Database Syst Rev. 2017 Oct 31;10(10):CD012024. doi: 10.1002/14651858.CD012024.pub2.
8
Antenatal corticosteroids prior to planned caesarean at term for improving neonatal outcomes.
Cochrane Database Syst Rev. 2021 Dec 22;12(12):CD006614. doi: 10.1002/14651858.CD006614.pub4.
9
Planned early delivery versus expectant management for hypertensive disorders from 34 weeks gestation to term.
Cochrane Database Syst Rev. 2017 Jan 15;1(1):CD009273. doi: 10.1002/14651858.CD009273.pub2.
10
Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth.
Cochrane Database Syst Rev. 2022 Aug 9;8(8):CD006764. doi: 10.1002/14651858.CD006764.pub4.

本文引用的文献

1
Aggressive infantile myofibromatosis with intestinal involvement.
Mol Cell Pediatr. 2021 Jun 16;8(1):7. doi: 10.1186/s40348-021-00117-9.
2
Association of PDGFRB Mutations With Pediatric Myofibroma and Myofibromatosis.
JAMA Dermatol. 2019 Aug 1;155(8):946-950. doi: 10.1001/jamadermatol.2019.0114.
4
PDGFRB gain-of-function mutations in sporadic infantile myofibromatosis.
Hum Mol Genet. 2017 May 15;26(10):1801-1810. doi: 10.1093/hmg/ddx081.
6
Infantile myofibromatosis: a series of 28 cases.
J Am Acad Dermatol. 2014 Aug;71(2):264-70. doi: 10.1016/j.jaad.2014.03.035. Epub 2014 Jun 2.
7
Mutations in PDGFRB cause autosomal-dominant infantile myofibromatosis.
Am J Hum Genet. 2013 Jun 6;92(6):1001-7. doi: 10.1016/j.ajhg.2013.04.024. Epub 2013 May 23.
8
A recurrent PDGFRB mutation causes familial infantile myofibromatosis.
Am J Hum Genet. 2013 Jun 6;92(6):996-1000. doi: 10.1016/j.ajhg.2013.04.026. Epub 2013 May 23.
9
Infantile myofibromatosis with multiple congenital anomalies.
Pediatr Dermatol. 2005 May-Jun;22(3):281-2. doi: 10.1111/j.1525-1470.2005.22329.x.
10
Juvenile fibromatoses.
Cancer. 1954 Sep;7(5):953-78. doi: 10.1002/1097-0142(195409)7:5<953::aid-cncr2820070520>3.0.co;2-w.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验